Foggia

The trials here

What the 11 trials at this site are about, from their registry records.

Conditions

• Asthma2 trials
• COPD2 trials
• Liver and biliary tract cancer2 trials
• Chronic kidney disease1 trial
• Chronic lymphocytic leukaemia1 trial
• Fatty liver disease (MASLD/MASH)1 trial
• Heart failure1 trial
• Idiopathic pulmonary fibrosis1 trial
• Liver cirrhosis1 trial

Phase

• Phase 23 trials
• Phase 31 trial
• Phase 41 trial

Status

• Completed5 trials
• Active, not recruiting3 trials
• Recruiting2 trials
• Not yet recruiting1 trial

Lead sponsor

• AstraZeneca11 trials

Running trials

• Recruiting

  A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

  NCT07652658· Phase 2· AstraZeneca· Source

• Recruiting

  MONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic Decompensation, Quality of Life, Effectiveness, and Safety of Tremelimumab Plus Durvalumab in Patients With Advanced or Unresectable Hepatocellular Carcinoma Who Have Received no Prior Systemic Treatment.

  NCT07607769· AstraZeneca· Source

• Recruiting

  A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy

  NCT07214753· AstraZeneca· Source

• Active, not recruiting

  Observational Study on the Clinical Profile of Patients With Uncontrolled Severe Asthma Treated With Tezepelumab in Italy

  NCT06948396· AstraZeneca· Source

• Active, not recruiting

  Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs)

  NCT05771480· Phase 3· AstraZeneca· Source

• Active, not recruiting

  Acalabrutinib Real World Italian obSErvational Study -ARISE

  NCT06205498· AstraZeneca· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Asthma1 recruiting
• Idiopathic pulmonary fibrosis1 recruiting
• Liver and biliary tract cancer1 recruiting

Closed trials

• Completed

  Outcomes in Real-life After Initation of Treatment With Trixeo (Budesonide / Glycopyrronium / Formoterol)

  NCT05862545· AstraZeneca· Source

• Completed

  An Efficacy and Safety Study of Mitiperstat (AZD4831) (MPO Inhibitor) vs Placebo in the Treatment of Moderate to Severe COPD.

  NCT05492877· Phase 2· AstraZeneca· Source

• Completed

  A Study to Evaluate the Safety and Efficacy of Cotadutide Given by Subcutaneous Injection in Adult Participants With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis

  NCT05364931· Phase 2· AstraZeneca· Source

• Completed

  Observation of Italian Patients With Heart Failure Being Treated With Dapagliflozin in Clinical Practice

  NCT05250011· AstraZeneca· Source

• Completed

  Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study

  NCT05347693· Phase 4· AstraZeneca· Source